| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
357.8700 | 359.7000 | 401 | 145.8000 | 119.8000 |
| Cost of Revenue
|
-28.3200 | -23.8440 | -28.0720 | 0 | -- |
|
Gross Profit
|
329.5500 | 335.8560 | 372.9280 | 145.8000 | -- |
| Selling, General and Administrative Expenses
|
-5,180.7990 | -5,888.3170 | -5,221.2090 | -11,331.9830 | -15,580.4730 |
|
Research and Development Expenses
|
-9,374.0820 | -10,094.6710 | -6,706.9130 | -4,034.5910 | -3,513.3520 |
| Other Income/Expense, Operating
|
0 | -- | 0 | 83.3330 | 110.5180 |
|
Operating Income/Expenses
|
-14,554.8810 | -15,982.9880 | -11,928.1220 | -15,283.2410 | -18,983.3070 |
|
Total Operating Profit/Loss
|
-14,225.3310 | -15,647.1320 | -11,555.1940 | -15,137.4410 | -18,863.5070 |
| Total Net Finance Income/Expense
|
266.2070 | 266.2070 | 616.0770 | 552.2930 | 11.6500 |
| Net Investment Income
|
2,981.2210 | 1,121.5020 | 1,808.8860 | 3,997.7800 | 5,272.4730 |
| Irregular Income/Expenses
|
-- | -- | -- | 0 | 250 |
|
Other Income/Expense, Non-Operating
|
21.2880 | 17.4480 | 150.8500 | 169.6640 | 107.0880 |
|
Non-Operating Income/Expenses, Total
|
3,168.7500 | 1,405.1570 | 2,575.8130 | 4,719.7370 | 5,641.2110 |
|
Pretax Income
|
-11,056.5810 | -14,241.9750 | -8,979.3810 | -10,417.7040 | -13,222.2960 |
|
Net Income from Continuing Operations
|
-11,056.5810 | -14,241.9750 | -8,979.3810 | -10,417.7040 | -13,222.2960 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-11,056.5810 | -14,241.9750 | -8,979.3810 | -10,417.7040 | -13,222.2960 |
|
Net Income after Non-Controlling/Minority Interests
|
-11,056.5810 | -14,241.9750 | -8,979.3810 | -10,417.7040 | -13,222.2960 |
|
Net Income Available to Common Stockholders
|
-11,056.5810 | -14,241.9750 | -8,979.3810 | -10,417.7040 | -13,222.2960 |
|
Diluted Net Income Available to Common Stockholders
|
-11,056.5810 | -14,241.9750 | -8,979.3810 | -10,417.7040 | -13,222.2960 |
| Basic EPS
|
-21.40 | -31.60 | -23.20 | -49.40 | -73.00 |
| Diluted EPS
|
-21.40 | -31.60 | -23.20 | -49.40 | -73.00 |
|
Basic Weighted Average Shares Outstanding
|
566.7890 | 449.6560 | 388.1970 | 210.9170 | 180.8930 |
|
Diluted Weighted Average Shares Outstanding
|
566.7890 | 449.6560 | 388.1970 | 210.9170 | 180.8930 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-11,056.5810 | -14,508.1820 | -9,595.4580 | -10,969.9970 | -13,233.9460 |
|
EBITDA
|
-10,845.9830 | -14,298.1970 | -9,406.4020 | -10,804.2620 | -13,113.4010 |
|
Normalized EBITDA
|
-12,215.0100 | -12,094.0730 | -8,402.7220 | -7,019.0750 | -6,023.0120 |
|
Normalized Income
|
-12,425.6080 | -12,037.8510 | -7,975.7010 | -6,632.5170 | -6,131.9070 |
|
Total Unusual Items
|
-1,369.0270 | 2,204.1240 | 1,003.6800 | 3,785.1870 | 7,090.3890 |
|
Total Unusual Items Excluding Goodwill
|
-1,369.0270 | 2,204.1240 | 1,003.6800 | 3,785.1870 | 7,090.3890 |
12/31/2022 - 12/5/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade